PRESCRIPTION DRUG ETHICAL MARK Senate SponsorsSen. Barack Obama, James T. Meeks, Martin A. Sandoval, Iris Y. Martinez-Jacqueline Y. Collins and M. Maggie Crotty 1/11/2005SenateSession Sine Die New ActCreates the Prescription Drug Ethical Marketing Act. Requires every manufacturer and labeler that sells prescription drugs in the State to disclose to the Director the value, nature, and purpose of any gift, fee, payment, subsidy, or other economic benefit provided in connection with detailing or promotional or other marketing activities by the company, directly or through its pharmaceutical marketers, to any physician, hospital, nursing home, pharmacist, health benefit plan administrator, or any other person in Illinois authorized to prescribe or dispense prescription drugs. Requires the Director to report to the Governor and the General Assembly on the disclosures. Provides exceptions to the disclosures. Provides for injunctive relief and civil penalties for failure to disclose. 2/4/2004SenateFiled with Secretary by Sen. Barack Obama 2/4/2004SenateFirst Reading 2/4/2004SenateReferred to Rules 2/18/2004SenateAssigned to Health & Human Services 2/25/2004SenateDo Pass Health & Human Services; 006-002-002 2/25/2004SenatePlaced on Calendar Order of 2nd Reading February 26, 2004 3/3/2004SenateAdded as Co-Sponsor Sen. James T. Meeks 3/23/2004SenateAdded as Co-Sponsor Sen. Martin A. Sandoval 3/24/2004SenateAdded as Co-Sponsor Sen. Iris Y. Martinez 3/24/2004SenateFiscal Note Requested by Sen. Dale A. Righter 3/24/2004SenateAdded as Chief Co-Sponsor Sen. Jacqueline Y. Collins 4/1/2004SenateAdded as Co-Sponsor Sen. M. Maggie Crotty 8/24/2004SenatePursuant to Senate Rule 3-9(b) / Referred to Rules 1/11/2005SenateSession Sine Die